Cardiology
Partner With Us
Advertisement
Conexiant chevron_right Cardiology chevron_right Six Minute Walk Test Flags Risk in ATTRCM
From the Journals

Six-Minute Walk Test Flags Risk in ATTR-CM

In a single‑center registry, baseline and 1‑year distances below 350 meters identified higher‑risk patients with transthyretin amyloid cardiomyopathy; changes in distance were prognostic mainly with stable therapy.

Conexiant
Full Article Summary Notecard
  1. A baseline 6MWD under 350 meters indicates higher mortality in ATTR-CM patients.
  2. The study included 252 patients with a median follow-up of nearly 22 months.
  3. Dr. Michael Poledniczek led the research at the Medical University of Vienna.
  4. Hazard ratios indicated significant mortality risks at both baseline and one year follow-up.
  5. Changes in 6MWD were less reliable for prognosis following treatment adjustments.

Source: Frontiers in Medicine

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.